Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-17

Clinical Trial Update: Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia [NA]

View source ↗

Summary

A clinical trial update examining how COMT genotype affects response to cognitive remediation in individuals with chronic schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Manhattan Psychiatric Center | Conditions: Chronic Schizophrenia | NA | Status: UNKNOWN